Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XWENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XWENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
B.1.177.26EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.26EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.26ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.26ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.26EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.87EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.87EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.87ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.87ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.87EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.87EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.87ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.87ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.39.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.39.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.39.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.39.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-12382.3Germany
FL.39.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.39.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-15334.4China
FL.39.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.39.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-15680China
BA.5.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.4.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.4.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.4.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.4.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.4.1.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.4.1.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GA.4.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.4.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.45EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.2.45ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.2.45ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.2.45EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.45EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used